ICMR Supports Nationwide Trial to Study Reduced-Cost PARP Inhibitor Dosing in Ovarian Cancer
The Indian Council of Medical Research (ICMR) has funded a new pan-India clinical trial to examine a more affordable and…
Dr Asima Mukhopadhyay
Read More